BioSpace News Archive

Biotech Beach

Evofem Biosciences Announces New Location and COVID-19 Preventative Measures for 2020 Annual Meeting Scheduled for May 12, 2020

Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that the location of its annual general meeting scheduled for May 12, 2020 at 8:00 am PDT has been moved to the 6th floor boardroom at 12400 High Bluff Dr., San Diego, CA 92130.

May 1, 2020
·
2 min read
Pharm Country

Model Projects County-Level COVID-19 Spread with Multiple Reopening Scenarios

New data released by PolicyLab at Children’s Hospital of Philadelphia show projected COVID-19 cases by county based on when and how aggressively communities reopen non-essential businesses.

May 1, 2020
·
4 min read
Business

Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020

Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, Ritter” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today reported financial results for the first quarter ended March 31, 2020.

May 1, 2020
·
10 min read
Pharm Country

Advanced Radiology Partners with eInformatics to Create a Safer Patient Experience

Connecticut’s leading independent radiology group collaborates with award winning provider of healthcare software solutions to provide a safer patient experience

May 1, 2020
·
3 min read
Business

UPDATE -- Dentsply Sirona to Host First Quarter 2020 Conference Call on May 8th

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that the Company will host an investor conference call and live webcast on Friday, May 8, 2020 at 8:30 am ET and send out an earnings press release earlier that morning.

May 1, 2020
·
1 min read
Policy

Coronavirus (COVID-19) Update: Daily Roundup - May 1, 2020

The U.S. Food and Drug Administration continued to take action in the ongoing response effort to the COVID-19 pandemic

May 1, 2020
·
3 min read
Advisory - Axid (nizatidine) drug recalled due to presence of NDMA

The Pendopharm Division of Pharmascience Inc. is recalling two lots of Axid (nizatidine) from the Canadian market, as they contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), which is a probable human carcinogen, at the maximum acceptable limit.

May 1, 2020
·
3 min read
Independent site management organisation Panthera expands vaccine trial capacity

Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK

May 1, 2020
·
2 min read
Business

ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer - Dr. Wieland Wolf Retires

ProBioGen AG, a premier, Berlin-based CDMO for developing and manufacturing complex therapeutic glycoproteins today announced that Dr. Lutz Hilbrich, an experienced biotech executive, has been named Chief Executive Officer, effective June 1, 2020

May 1, 2020
·
3 min read